Rockwell Medical (RMTI) EBIAT (2016 - 2025)
Rockwell Medical's EBIAT history spans 16 years, with the latest figure at -$554000.0 for Q4 2025.
- For Q4 2025, EBIAT rose 26.72% year-over-year to -$554000.0; the TTM value through Dec 2025 reached -$5.3 million, down 1007.08%, while the annual FY2025 figure was -$5.3 million, 1007.08% down from the prior year.
- EBIAT reached -$554000.0 in Q4 2025 per RMTI's latest filing, up from -$1.8 million in the prior quarter.
- In the past five years, EBIAT ranged from a high of $1.7 million in Q3 2024 to a low of -$8.9 million in Q4 2021.
- Average EBIAT over 5 years is -$3.3 million, with a median of -$1.8 million recorded in 2023.
- Peak YoY movement for EBIAT: soared 188.89% in 2024, then crashed 534.99% in 2025.
- A 5-year view of EBIAT shows it stood at -$8.9 million in 2021, then soared by 73.58% to -$2.4 million in 2022, then surged by 35.99% to -$1.5 million in 2023, then soared by 50.0% to -$756000.0 in 2024, then increased by 26.72% to -$554000.0 in 2025.
- Per Business Quant, the three most recent readings for RMTI's EBIAT are -$554000.0 (Q4 2025), -$1.8 million (Q3 2025), and -$1.5 million (Q2 2025).